Searched for
SUN PHARMA SUBSIDIARY
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- IHH-Daiichi legal battle nears verdict on September 10A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Stocks in news: LIC, Maruti Suzuki, Sun Pharma, TCS, HULIndian markets extended their gains on Friday, with analysts predicting a steady recovery towards the 24,300-24,700 zone. Several prominent...
- US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip BandyopadhyayIndian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expe...
- Sun Pharma shares in spotlight as company to sell 100% stake in Japanese armSun Pharma stated that it has entered into an agreement with Zaza Industrial Holdings K.K., Japan, to sell 100% of its shares in Sun Pharma...
- Sun Pharma subsidiary partners with Aclaris Therapeutics for licensing agreementAs per the pact, Aclaris grants Sun Pharma exclusive rights to specific patents for using deuruxolitinib, Sun Pharma's JAK inhibitor, or ot...
- Sun Pharma settles patent litigation with Celgene Corporation for cancer drug RevlimidDrug major Sun Pharma has reached an agreement with Celgene Corporation, to resolve the patent litigation regarding generic version of Revl...
- Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...
- NCLT rejects Sun Pharma’s plan to demerge overseas subsidiaryThe company had approached the Ahmedabad bench of NCLT for an approval to transfer investment undertakings from Sun Pharma to its Netherlan...
- Got 2 queries from Sebi: Sun PharmaSun Pharma’s shares have been volatile in the last two months.
- Sun Pharma replaces domestic formulations distributor with its own subsidiaryLast week, Sun Pharmaceutical asked markets regulator Sebi to look into the issues of certain entities and individuals allegedly adopting u...
- Sun Pharma restructures certain business decisions to address corporate governance issuesThe company "unequivocally" denied that it had lent or stood guarantee for Suraksha Realty
- Why Sun Pharma is under a cloud: Decoding Aditya Medisales linkA purported whistleblower letter has highlighted Sun Pharma's dealings with subsidiary AML.
- Sun Pharma arm gets USFDA nod for epilepsy drugThe subsidiary concerned had in-licensed Elepsia XR from Sun Pharma Advanced Research Company (SPARC) in July 2016.
- USFDA accepts Sun Pharma arm's ophthalmic drug applicationSun Pharma said that post the USFDA approval, OTX-101 will be commercialised in the US by Sun Ophthalmics, the branded ophthalmics division...
- Sun Pharma launches generic versions of Daiichi Sankyo's high blood pressure drugs in USThese brands together recorded US sales of approximately $2.5 billion between August 31, 2015 and August 31, 2016, Sun Pharma said, citing ...
- Sun Pharma divests Ohio unitIndia's largest drug maker Sun Pharma has sold its Bryan unit in Ohio to Nostrum laboratories as part of its consolidation of manufacturing...
- Sun Pharma settles Novartis lawsuit over leukemia drugSun Pharmaceutical Industries Ltd said it was allowed to launch a generic version of Novartis' leukemia drug Gleevec in the US
Load More
